Related Experiment Video

Updated: Jul 18, 2026

Isolation and Physiological Analysis of Mouse Cardiomyocytes
11:02

Isolation and Physiological Analysis of Mouse Cardiomyocytes

Published on: September 7, 2014

[Cardiovascular effects of hyperthyroidism and their treatment]

E Tielens1, T J Visser, G Hennemann

  • 1Medisch Centrum Rijnmond-Zuid, locatie Zuider, afd. Inwendige Geneeskunde, Rotterdam. emile.tielens@wanadoo.nl

Nederlands Tijdschrift Voor Geneeskunde
|June 5, 2002
PubMed

Insights

Hyperthyroidism significantly impacts heart rate and function, decreasing cardiac reserve despite increased contractility. Beta-blockers help manage palpitations by reducing heart rate and atrial extrasystoles.

Area of Science:

  • Cardiology
  • Endocrinology

Context:

  • Hyperthyroidism presents with significant cardiovascular manifestations affecting heart rate and function.
  • Understanding these cardiac effects is crucial for managing patients with thyroid disorders.

Purpose:

  • To elucidate the complex relationship between hyperthyroidism and cardiac function.
  • To clarify the mechanisms behind increased contractility and diminished cardiac reserve in hyperthyroid states.

Summary:

  • Hyperthyroidism increases cardiac contractility indirectly via peripheral vasodilation but diminishes overall cardiac reserve.
  • While the circulation may appear hyperadrenergic, cardiac catecholamine sensitivity is not elevated.
  • Beta-blockers alleviate palpitations by slowing heart rate and reducing atrial extrasystoles, not by normalizing contractility.

Impact:

  • Highlights that heart failure in hyperthyroidism typically occurs in patients with pre-existing cardiac conditions.
  • Emphasizes the importance of rapid thyroid hormone reduction in severe heart failure.
  • Notes the ongoing debate regarding anticoagulation for thyrotoxic atrial fibrillation, with a general recommendation for high-risk patients.

More Related Videos

In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse04:14

In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse

Published on: October 6, 2023

Related Concept Videos

Increased pulse rate01:17

Increased pulse rate

Tachycardia is a condition marked by an abnormally fast or irregular heart rate, surpassing the typical resting rate. In adults, tachycardia is characterized by a pulse rate ranging from 100 to 180 beats per minute. The increased heart rate can result in inadequate blood flow to various body parts, ultimately diminishing the oxygen supply to organs and tissues.
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...